iTind – natural and safe treatment for prostate enlargement

Benign prostatic hyperplasia (BPH) is a common condition that affects an increasing number of men as they age, causing difficulties with urination, frequent visits to the toilet and sleep disturbances, among other things. Although BPH is not cancer, it can significantly reduce quality of life. A modern and minimally invasive solution to this problem is the iTind procedure – a clinically proven method that safely and effectively relieves the symptoms of prostate enlargement without the need for daily medication or surgery.

50%

BPH at age 60

90%

BPH at age 85

Benign prostatic hyperplasia (BPH) – a complete guide

Benign prostatic hyperplasia (BPH) is a medical term describing prostate enlargement, a condition that can affect urination. It is a very common condition. Many men worry that BPH can turn into prostate cancer. This is not true. BPH is not cancer and cannot turn into cancer. However, prostate enlargement can interfere with sleep, social life and have a serious impact on quality of life.

How to recognise BPH? The most common symptoms

An enlarged prostate can put pressure on the urethra, the tube through which urine flows. This can affect urination and cause:

  • Difficulty starting to urinate.
  • Inability to completely empty the bladder.
  • Frequent/urgent need to urinate.
  • Weak urine stream.
  • Frequent night-time urination.
Graphic depicting prostate hypertrophy. Graphic property: Olympus

iTind – an innovative solution for men with prostate problems

iTind is a minimally invasive and clinically proven treatment that provides fast and effective relief from BPH symptoms.

The procedure involves implanting a small device into the prostate for 5–7 days, after which it is completely removed. Once implanted, iTind expands and exerts gentle pressure, remodelling the tissue and creating a wider channel through which urine can flow.

The iTind procedure is an ideal alternative to prescription drugs or invasive surgical procedures. You should consider iTind if you do not want to take tablets every day or if you have tried standard pharmacological treatments and are not satisfied with the level of symptom relief or side effects.

Dr Anna Bonder-Nowicka – prostate treatment specialist – iTind procedure

Effects of iTind – what can you expect?

The procedure can be performed under light sedation or local anaesthesia, usually takes less than 30 minutes, and does not require heating or removal of prostate tissue.

iTind is designed not only to effectively relieve symptoms, but also to provide peace of mind.

Benefits of using iTind:

  • Fast and effective symptom relief.
  • Lasting results.
  • Quick return to daily life.
  • No need for general anaesthesia.
  • Routine procedure without a catheter.
  • The procedure does not involve permanent implantation.
  • Preserves sexual and ejaculatory functions.
  • Preserves control over urination.

What can I expect from the iTind procedure?

The iTind procedure is a minimally invasive procedure performed by a urologist that allows you to quickly return to your daily activities. The device remains in the prostate for several days, after which it is safely removed and the patient gradually experiences relief from the symptoms of prostate enlargement.

The iTind device – prostate treatment – Dr Anna Bonder-Nowicka
STEP 1

Introduction of iTind

Introduction of iTind

The iTind procedure will be performed by a urologist in an operating theatre or outpatient clinic. The urologist may give the patient a mild sedative and local anaesthetic.

A thin tube with a miniature camera will be inserted into the urethra to determine the placement of the iTind device. The urologist will then place the iTind device in the prostate.

Once the device is in place, the patient should be able to urinate freely and will be discharged home. A catheter is not usually required.

STEP 2

iTind – Implantation period

Implantation period

Over the next 5–7 days, you can return to most normal activities, depending on how you feel. You may experience pain in your lower abdomen and discomfort when sitting. You may feel a more frequent need to urinate and a greater sense of urgency. There may also be blood in your urine. These are normal reactions.

STEP 3

iTind – Removal

Removal of iTind

After 5–7 days, your urologist will completely remove the iTind device using a flexible silicone catheter. You can resume normal activities 1–2 days after removal.

A quick return to everyday life!

iTind in practice – patients’ most frequently asked questions

Together with your urologist you will review your symptoms, routine and lifestyle needs to determine if iTind is suitable for you. The iTind procedure is a new alternative to prescription drugs or surgery. It is designed for men who want to preserve a high quality of life and those that want to preserve sexual activity.

After the iTind device has been inserted, you may be asked to stay in the hospital for a couple of hours (this is normal). Upon returning home you may return to most normal activities depending on how comfortable you feel.

Most patients start to feel symptom relief as soon as the device has been removed. Symptoms typically continue to improve over the next 6 to 12 weeks.

The device is designed to preserve the sexual and ejaculatory function. Its positioning aims to ensure that no damage is caused to sperm ducts or sphincters and to minimize risks of sexual dysfunction.

Durability has been demonstrated out to three years in terms of symptom improvement, urinary fl ow and quality of life in a signifi cant number of patients. The iTind treatment does not preclude retreatment or other BPH treatments, should they be needed or desired in the future.

Patient experience is variable. Most patients experience only mild to moderate discomfort with the iTind device is in place.

Depending on your medical history and anatomy, the iTind procedure may not be the best treatment for you. Consult with your doctor to determine whether the iTind procedure is right for you.

In clinical studies there have been no indications of long-term adverse side effects. Since the iTind device is completely removed at the end of the treatment week, there is no risk of implant migration, encrustation, or tissue overgrowth. Moreover, there are no obstacles in maintaining a regular prostate screening program, including physical exams or any type of imaging, such as MRI, if needed.

Published with the consent of Olympus Poland